Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD-A Pilot Study

被引:0
作者
Karauda, Tomasz [1 ]
Milkowska-Dymanowska, Joanna [1 ]
Kumor-Kisielewska, Anna [1 ]
Piotrowski, Wojciech J. [1 ]
Bialas, Adam J. [1 ,2 ]
机构
[1] Med Univ Lodz, Dept Pneumol, PL-90419 Lodz, Poland
[2] Blessed Rafal Chylinski Mem Hosp Lung Dis, Reg Med Ctr Lung Dis & Rehabil, Dept Pulm Rehabil, PL-91520 Lodz, Poland
关键词
chronic obstructive pulmonary disease; COPD; IL-16; IL-25; survival analysis; immunopathology of COPD; PULMONARY; INFLAMMATION; IL-25; CELLS;
D O I
10.3390/jcm13175188
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exacerbation of chronic obstructive pulmonary disease (ECOPD) significantly impact health status, hospitalization rates, and disease progression, and are linked to increased mortality. Predictive factors for ECOPD are therefore of considerable interest. The limited understanding of interleukin 16 (IL-16) and IL-25 role in ECOPD provided the rationale for this study. Methods: Fifty ex-smokers diagnosed with COPD (22 ECOPD and 28 patients in the stable phase of the disease) underwent prospective analysis to evaluate the role of I IL-25 as predictive markers of clinical outcomes in ECOPD. Results: We observed a significantly lower IL-16 and higher IL-25 concentrations among ECOPD patients (p = 0.002 and p = 0.01 respectively). We also detected a significant negative correlation between IL-16 and neutrophil-to-lymphocyte ratio (NLR) (p = 0.04) and a significant negative correlation between IL-25 concentration and absolute eosinophil count (p = 0.04). In the entire group, we observed a positive correlation between IL-16 and both FEV1 and FVC, both expressed as a percentage of reference value, (p = 0.002 and p = 0.0004 respectively). However, after stratification to ECOPD and stable COPD group, significance maintained for FVC (p = 0.045 for ECOPD and p = 0.02 for stable COPD). In survival analysis, we detected significantly lower all-cause mortality for 3rd tertile of IL-16 concentrations, with a hazard ratio of 0.33 (95%CI: 0.11-0.98; p = 0.04). Conclusions: Lower IL-16 levels among ECOPD patients may indicate a feedback mechanism linked to heightened Th1 response activation. Observed correlations with ventilatory parameters and survival also seems to reflect this mechanism. The higher IL-25 concentrations observed in ECOPD patients, along with the negative correlation with absolute eosinophil count and eosinopenia, suggest multifactorial regulation and independent functions of eosinophils and IL-25. Hypothetically, this paradox may be related to the Th1/Th2 imbalance favoring Th1 response. Obtained results should be reproduced in larger size samples.
引用
收藏
页数:9
相关论文
共 32 条
  • [21] Cutting edge: CD4 is not required for the functional activity of IL-16
    Mathy, NL
    Bannert, N
    Norley, SG
    Kurth, R
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (09) : 4429 - 4432
  • [22] Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease
    Ning, W
    Li, CJ
    Kaminski, N
    Feghali-Bostwick, CA
    Alber, SM
    Di, YPP
    Otterbein, SL
    Song, RP
    Hayashi, S
    Zhou, ZH
    Pinsky, DJ
    Watkins, SC
    Pilewski, JM
    Sciurba, FC
    Peters, DG
    Hogg, JC
    Choi, AMK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (41) : 14895 - 14900
  • [23] Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives
    Paliogiannis, Panagiotis
    Fois, Alessandro G.
    Sotgia, Salvatore
    Mangoni, Arduino A.
    Zinellu, Elisabetta
    Pirina, Pietro
    Negri, Silvia
    Carru, Ciriaco
    Zinellu, Angelo
    [J]. EUROPEAN RESPIRATORY REVIEW, 2018, 27 (147)
  • [24] Polarized localization of epithelial CXCL11 in chronic obstructive pulmonary disease and mechanisms of T cell egression
    Porter, Joanna C.
    Falzon, Mary
    Hall, Alan
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (03) : 1866 - 1877
  • [25] Interleukin-16 in tuberculous and malignant pleural effusions
    Qin, XJ
    Shi, HZ
    Huang, ZX
    Kang, LF
    Mo, WM
    Wu, C
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (04) : 605 - 611
  • [26] Rahimi-Rad Mohammad Hossein, 2015, Maedica (Bucur), V10, P10
  • [27] Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity
    Sharkhuu, T.
    Matthaei, K. I.
    Forbes, E.
    Mahalingam, S.
    Hogan, S. P.
    Hansbro, P. M.
    Foster, P. S.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (12) : 1575 - 1583
  • [28] IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice
    Tamachi, Tomohiro
    Maezawa, Yuko
    Ikeda, Kei
    Kagami, Shin-ichiro
    Hatano, Masahiko
    Seto, Yohei
    Suto, Akira
    Suzuki, Kotaro
    Watanabe, Norihiko
    Saito, Yasushi
    Tokuhisa, Takeshi
    Iwamoto, Itsuo
    Nakajima, Hiroshi
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (03) : 606 - 614
  • [29] Weckler BC, 2024, CHEST, V166, P1329, DOI 10.1016/j.chest.2024.05.041
  • [30] Immunophenotype in acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study
    Xiong, Xiao-feng
    Zhu, Min
    Wu, Hong-xia
    Fan, Li-li
    Cheng, De-yun
    [J]. RESPIRATORY RESEARCH, 2022, 23 (01)